Skip to main content
main-content

Zeitschrift

Diabetes Therapy

Research, treatment and education of diabetes and related disorders

Diabetes Therapy OnlineFirst articles

15.02.2020 | Original Research Open Access

Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes

It has been previously shown that achieving and maintaining target glycaemic control in pregnant women with pre-existing type 1 diabetes (pT1D) can be extremely challenging in clinical settings [ 1 ]. However, obtaining tight glycaemic control is …

12.02.2020 | Original Research Open Access

SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study

In 2018, on the basis of post-marketing adverse effects surveillance data, the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) mandated updates to the prescribing information of all members of the sodium–glucose …

08.02.2020 | Brief Report Open Access

Acute Complications of Diabetes Among Pilgrims During Hajj 2017: A Brief Report

Hajj is a large annual mass gathering event in Islamic culture that localizes in Mecca, Saudi Arabia. Hajj rituals require physical activities including walking for long distances every day [ 1 ]. According to the statistics of Hajj 2017, there …

04.02.2020 | Original Research Open Access

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by progressive β-cell dysfunction that leads to insulin deficiency. In China, primary healthcare coverage is insufficient to provide the extent of care required, with the result …

03.02.2020 | Original Research Open Access

Application of Machine Learning Models to Evaluate Hypoglycemia Risk in Type 2 Diabetes

Rising healthcare costs in the USA and around the world are a growing concern to global health economists. In 2016, the USA spent 17.8% of its gross domestic product on healthcare—nearly twice as much as other high-income countries—while …

Aktuelle Ausgaben

Über diese Zeitschrift

Diabetes Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of diabetes therapies. Studies relating to diagnosis, devices and diabetes technology, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world.

Moving forward from traditional publishing, Diabetes Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

Diabetes Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

Upon acceptance of your article for publication, you will be required to pay the article processing charge of £230/$360 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.

For more information about the journal, please contact hayley.wood@springer.com or see the News page for the latest journal offers.

Weitere Informationen

Neu im Fachgebiet Innere Medizin

Meistgelesene Bücher aus der Inneren Medizin

2017 | Buch

Rheumatologie aus der Praxis

Entzündliche Gelenkerkrankungen – mit Fallbeispielen

Dieses Fachbuch macht mit den wichtigsten chronisch entzündlichen Gelenk- und Wirbelsäulenerkrankungen vertraut. Anhand von über 40 instruktiven Fallbeispielen werden anschaulich diagnostisches Vorgehen, therapeutisches Ansprechen und der Verlauf …

Herausgeber:
Rudolf Puchner

2016 | Buch

Ambulant erworbene Pneumonie

Was, wann, warum – Dieses Buch bietet differenzierte Diagnostik und Therapie der ambulant erworbenen Pneumonie zur sofortigen sicheren Anwendung. Entsprechend der neuesten Studien und Leitlinien aller wichtigen Fachgesellschaften.

Herausgeber:
Santiago Ewig

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise